Article Information
History
- January 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bas Calcoen1,
- Kim Callebaut2,
- Aline Vandenbulcke1,
- Nico Callewaert2,
- Xavier Bossuyt3,
- Johan Van Weyenbergh4,
- Piet Maes4,
- Maya Imbrechts5,
- Thomas Vercruysse6,
- Hendrik Jan Thibaut6,
- Dorinja Zapf7,
- Kersten Dieckmann7,
- Karen Vanhoorelbeke1,5,
- Nick Geukens5,
- Simon De Meyer1 and
- Wim Maes5,*
- 1Laboratory for Thrombosis Research, KU Leuven campus Kulak Kortrijk, Kortrijk, Belgium
- 2AZ Groeninge Hospital, Department of Laboratory Medicine, Kortrijk, Belgium
- 3Department of Microbiology, Immunology and Transplantation, KU Leuven and Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
- 4Laboratory for Clinical and Epidemiological Virology, KU Leuven Rega Institute, Leuven, Belgium
- 5PharmAbs, The KU Leuven Antibody Center, KU Leuven, Leuven, Belgium,
- 6Laboratory of Virology and Chemotherapy KU Leuven Rega Institute, Leuven, Belgium
- 7Institut für experimentelle Immunologie, EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany
- ↵*Correspondence:
Wim Maes, wim.maes{at}kuleuven.be